Some years ago, the scientific world of CML questioned the potential role of exosomes derived from CML cells as biomarkers and new targets for the detection of the BCR-ABL1 transcript. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.